Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- ABC transporter B5 (1)
- Alloantigen (1)
- Allogeneic stem cell transplantation (1)
- Article (1)
- Bone (1)
-
- Cell subpopulation (1)
- Com-position (1)
- Graft survival (1)
- Heart transplantation (1)
- Human (1)
- Immune evasion (1)
- Immunoregulation (1)
- Immunoregulatory dermal cell (1)
- Immunotherapy (1)
- In vivo study (1)
- Lymphocyte proliferation (1)
- Major histocompatibility complex (1)
- Method (1)
- Muscle (1)
- Priority journal (1)
- Programmed death 1 receptor (1)
- Protein expression (1)
- Protein function (1)
- Protein purification (1)
- Regional (1)
- Regulatory T lymphocyte (1)
- Segmentation (1)
- Skin cell (1)
- Standardisation (1)
- T lymphocyte activation (1)
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Segmental Musculoskeletal Examinations Using Dual-Energy X-Ray Absorptiometry (Dxa): Positioning And Analysis Considerations, Nicolas H. Hart, Sophia Nimphius, Tania Spiteri, Jodie L. Cochrane, Robert U. Newton
Segmental Musculoskeletal Examinations Using Dual-Energy X-Ray Absorptiometry (Dxa): Positioning And Analysis Considerations, Nicolas H. Hart, Sophia Nimphius, Tania Spiteri, Jodie L. Cochrane, Robert U. Newton
Research outputs 2014 to 2021
Musculoskeletal examinations provide informative and valuable quantitative insight into muscle and bone health. DXA is one mainstream tool used to accurately and reliably determine body composition components and bone mass characteristics in-vivo. Presently, whole body scan models separate the body into axial and appendicular regions, however there is a need for localised appendicular segmentation models to further examine regions of interest within the upper and lower extremities. Similarly, in-consistencies pertaining to patient positioning exist in the litera-ture which influence measurement precision and analysis out-comes highlighting a need for standardised procedure. This paper provides standardised and reproducible: 1) positioning and analysis …
Abcb5 Identifies Immunoregulatory Dermal Cells, Tobias Schatton, Jun Yang, Sonja Kleffel, Mayuko Uehara, Steven R. Barthel, Christoph Schlapbach, Qian Zhan, Stephen Dudeney, Hansgeorg Mueller, Nayoung Lee, Juliane C. De Vries, Barbara Meier, Seppe Vander Beken, Mark M. Kluth, Christoph Ganss, Arlene H. Sharpe, Ana Maria Waaga-Gasser, Mohamed H. Sayegh, Reza Abdi, Karin Scharffetter-Kochanek, George F. Murphy, Thomas S. Kupper, Natasha Y. Frank, Markus H. Frank
Abcb5 Identifies Immunoregulatory Dermal Cells, Tobias Schatton, Jun Yang, Sonja Kleffel, Mayuko Uehara, Steven R. Barthel, Christoph Schlapbach, Qian Zhan, Stephen Dudeney, Hansgeorg Mueller, Nayoung Lee, Juliane C. De Vries, Barbara Meier, Seppe Vander Beken, Mark M. Kluth, Christoph Ganss, Arlene H. Sharpe, Ana Maria Waaga-Gasser, Mohamed H. Sayegh, Reza Abdi, Karin Scharffetter-Kochanek, George F. Murphy, Thomas S. Kupper, Natasha Y. Frank, Markus H. Frank
Research outputs 2014 to 2021
Cell-based strategies represent a new frontier in the treatment of immune-mediated disorders. However, the paucity of markers for isolation of molecularly defined immunomodulatory cell populations poses a barrier to this field. Here, we show that ATP-binding cassette member B5 (ABCB5) identifies dermal immunoregulatory cells (DIRCs) capable of exerting therapeutic immunoregulatory functions through engagement of programmed cell death 1 (PD-1). Purified Abcb5+ DIRCs suppressed T cell proliferation, evaded immune rejection, homed to recipient immune tissues, and induced Tregs in vivo. In fully major-histocompatibility-complex-mismatched cardiac allotransplantation models, allogeneic DIRCs significantly prolonged allograft survival. Blockade of DIRC-expressed PD-1 reversed the inhibitory effects of …